Holen Sie sich die Stockscreener-App
8.05
0.74%
-0.06
Schlusskurs vom Vortag:
$8.11
Offen:
$8
24-Stunden-Volumen:
22,525
Relative Volume:
0.77
Marktkapitalisierung:
$15.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-5.29%
1M Leistung:
+14.67%
6M Leistung:
+51.89%
1J Leistung:
+0.00%
1-Tages-Spanne:
$7.78
$8.1384
1-Wochen-Bereich:
$7.78
$8.90
52-Wochen-Spanne:
$2.90
$12.55
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Firmenname
Neuphoria Therapeutics Inc
Sektor
Branche
Telefon
781-439-5551
Adresse
100 SUMMIT DR, BURLINGTON
Vergleichen Sie NEUP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
8.05 | 15.25M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Bestätigt | Maxim Group | Buy |
| 2022-01-10 | Eingeleitet | Berenberg | Buy |
| 2022-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Eingeleitet | Evercore ISI | Outperform |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten
What MACD signals say about Neuphoria Therapeutics Inc.Real-Time Investment Signal Forecast with AI - Newser
What are analysts’ price targets for Neuphoria Therapeutics Inc. in the next 12 monthsTrack stocks with high upside potential easily - jammulinksnews.com
Real time scanner hits for Neuphoria Therapeutics Inc. explainedShort-Term Growth Watch with Signal Prediction - Newser
How many analysts rate Neuphoria Therapeutics Inc. as a “Buy”Consistent wealth multiplication - jammulinksnews.com
What drives Neuphoria Therapeutics Inc. stock priceTremendous return rates - jammulinksnews.com
Is Neuphoria Therapeutics Inc. a good long term investmentBreakout profit opportunities - jammulinksnews.com
How does Neuphoria Therapeutics Inc. generate profit in a changing economyAchieve rapid financial growth with expert help - jammulinksnews.com
What institutional investors are buying Neuphoria Therapeutics Inc. stockGet expert insights on market-moving stocks - jammulinksnews.com
Top Risks to Consider Before Buying Neuphoria Therapeutics Inc. StockTechnical Setup and Return Forecast Engine - Newser
Risk vs reward if holding onto Neuphoria Therapeutics Inc.Free Trade Setups With AI Powered Filters - Newser
Key metrics from Neuphoria Therapeutics Inc.’s quarterly dataBreakout Stock Opportunities with Low Drawdown - Newser
Published on: 2025-08-01 18:37:53 - metal.it
What MACD and RSI say about Neuphoria Therapeutics Inc.RSI and MACD Signal Summary with Trends - Newser
Analyzing drawdowns of Neuphoria Therapeutics Inc. with statistical toolsMachine Learning Stock Movement Detector - Newser
Heatmap analysis for Neuphoria Therapeutics Inc. and competitorsPortfolio Risk Distribution Analysis Tool - Newser
What makes Neuphoria Therapeutics Inc. stock attractive to long term investorsBuy Point Strategy with Profit Protection - Newser
How does Neuphoria Therapeutics Inc. compare to its industry peersWealth Building Review That Work - jammulinksnews.com
Combining machine learning predictions for Neuphoria Therapeutics Inc.Free Smart Money Tracking Signal Generator - Newser
Why is Neuphoria Therapeutics Inc. stock attracting strong analyst attentionDaily Trading Outlook With Proven Results - jammulinksnews.com
Competitive Positioning of Neuphoria Therapeutics Inc.: Is It Leading or LaggingFree Pattern Alert With ROI Driven Strategy - Newser
Neuphoria Therapeutics Inc. stock retracement – recovery analysisQuarterly Investment Outlook and Key Summary - Newser
Is Neuphoria Therapeutics Inc. stock a growth or value playFree Fundamental + Technical Hybrid Stock Tips - Newser
Why Neuphoria Therapeutics Inc. stock attracts strong analyst attentionFree Day Trading Signals With High Precision - Newser
Published on: 2025-07-30 03:10:38 - metal.it
How to integrate Neuphoria Therapeutics Inc. into portfolio analysis toolsFundamental Analysis for Value Stock Selection - Newser
Will Neuphoria Therapeutics Inc. stock benefit from interest rate changesEquity Forecast with Predictive AI Screener - Newser
What makes Neuphoria Therapeutics Inc. stock price move sharplyTrading Volume Anomaly Summary and Insight - Newser
How high can Neuphoria Therapeutics Inc. stock price go in 2025Real Stock Picks With Setup Verification - Newser
Published on: 2025-07-28 23:50:41 - beatles.ru
Published on: 2025-07-28 06:17:17 - jammulinksnews.com
Is Neuphoria Therapeutics Inc. stock overhyped or has real potentialMarket-beating returns - jammulinksnews.com
Will Neuphoria Therapeutics Inc. stock split in the near futureConsistent triple returns - jammulinksnews.com
Neuphoria Therapeutics Inc. Stock Analysis and ForecastStrongest growth potential - PrintWeekIndia
What analysts say about Neuphoria Therapeutics Inc. stockUnstoppable trading performance - Autocar Professional
Published on: 2025-07-22 18:43:03 - jammulinksnews.com
Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)
Es liegen keine Finanzdaten für Neuphoria Therapeutics Inc (NEUP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):